Zobrazeno 1 - 10
of 50
pro vyhledávání: '"J F Quay"'
Publikováno v:
Fibrinolysis. 7:264-274
We report the pharmacodynamic and pharmacokinetic evaluation of modified tissue plasminogen activator, LY210825, in the conscious dog upon intravenous (i.v.), subcutaneous (s.c.), and intramuscular (i.m.) injection of the single chain form of the thr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::893f64b313a248b5055e4cad84d81240
https://doi.org/10.1016/0268-9499(93)90135-i
https://doi.org/10.1016/0268-9499(93)90135-i
Autor:
Robert Theodore Vasileff, Brown Raymond Frank, J. F. Quay, F. T. Counter, J. A. Webber, E. O. Davidson, Terry D. Lindstrom, Jeffrey S. Kasher, William Henry Walker Lunn, Mitchell I. Steinberg, J. M. Jun. Morin, J. A. Eudaly, Paul W. Ensminger, R. E. Koehler, Allen S. Katner, Michael Dean Kinnick, John K. Swartzendruber, Jan R. Turner, David A. Preston, J. K. Shadle, Walter E. Wright, J. F. Stucky, K. D. Kurz, John L. Ott, Karen M. Zimmerman
Publikováno v:
ChemInform. 22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::386baf125ef02cf683bca51f026f46c4
https://doi.org/10.1002/chin.199104334
https://doi.org/10.1002/chin.199104334
Autor:
Philip J. Burck, J F Quay, J L Bobbitt, Trelia J. Craft, Charles V. Jackson, V G Crowe, J L Sundboom, B W Grinnell, Gerald F. Smith
Publikováno v:
Circulation. 82:930-940
LY210825, a recombinant tissue-type plasminogen activator (rt-PA), which contains the kringle-2 and serine protease functional domains of native tissue-type plasminogen activator, was previously produced by site-directed mutagenesis in a Syrian hamst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1431006b7bd026f80a6ddba01d5a6f0f
https://doi.org/10.1161/01.cir.82.3.930
https://doi.org/10.1161/01.cir.82.3.930
Publikováno v:
Journal of the American Veterinary Medical Association. 185(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ced77068eeed8036b8d6d6f3071a04b1
https://pubmed.ncbi.nlm.nih.gov/6392238
https://pubmed.ncbi.nlm.nih.gov/6392238
Autor:
S, Kukolja, W E, Wright, J F, Quay, J, Pfeil-Doyle, S E, Draheim, J A, Eudaly, R J, Johnson, J L, Ott, F T, Counter, R D, Cooper
Publikováno v:
Journal of medicinal chemistry. 31(10)
A number of 7-(arylacetamido)-3-substituted cephalosporins were prepared and tested in animals for oral absorbability. Bioavailability in mice, rats, dogs, and monkeys was determined after oral or parenteral administration. Oral bioavailability of fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dce19a75b02fc439d7f23768deec8bd0
https://pubmed.ncbi.nlm.nih.gov/3172134
https://pubmed.ncbi.nlm.nih.gov/3172134
The biotransformation of the parenterally effective cephalosporin antibiotic cefamandole nafate (I) has been studied in rats and dogs. After rapid in vivo hydrolysis of the nafate pharmaceutical form to cefamandole (II), the antibiotic was found to b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56e4e4725121034f16d4fffd2fa6656e
https://europepmc.org/articles/PMC352156/
https://europepmc.org/articles/PMC352156/
Publikováno v:
Microscopy & Microanalysis; Dec2017, Vol. 23 Issue 6, p1173-1188, 16p
Autor:
Brown, D. J.
Publikováno v:
Chemistry of Heterocyclic Compounds: The Naphthyridines; 2007, p295-336, 42p
Publikováno v:
Pyrazines: Supplement I, Chemistry of Heterocyclic Compounds, Volume 58; 2002, p461-513, 53p
Publikováno v:
Journal of Pharmacy & Pharmacology; May2008, Vol. 60 Issue 5, p543-585, 43p